<DOC>
	<DOCNO>NCT01601496</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy FUSION™ Vascular Graft .</brief_summary>
	<brief_title>Evaluation FUSION™ Vascular Graft Above Knee Targets</brief_title>
	<detailed_description>This study prospective , single arm , multi-center study evaluate FUSION™ Vascular Graft patency 30 day , 6 month , 1 year post operative complication associate bypass patency .</detailed_description>
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>Peripheral arterial occlusive disease require treatment femoral artery Patient participate clinical trial would conflict protocol Patient willing able followup visit exams Life expectancy less one year Patients treat coumadin ( warfarin ) prior baseline procedure Antiplatelet therapy within 7 day baseline procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>